{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:15:20Z","timestamp":1787840120633,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40261-016-0474-z","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T11:53:30Z","timestamp":1477482810000},"page":"187-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Relationship between Adverse Gastric Reactions and the Timing of Enteric-Coated Aspirin Administration"],"prefix":"10.1007","volume":"37","author":[{"given":"Weijun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,26]]},"reference":[{"key":"474_CR1","first-page":"525","volume":"61","author":"JJ VanWormer","year":"2012","unstructured":"VanWormer JJ, Greenlee RT, McBride PE, Peppard PE, Malecki KC, Che J, et al. Aspirin\u00a0for primary prevention of CVD: are the right people using it? J Fam Pract. 2012;61:525\u201332.","journal-title":"J Fam Pract"},{"key":"474_CR2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/eci.12575","volume":"46","author":"IC Wu","year":"2016","unstructured":"Wu IC, Hsieh HM, Yu FJ, Wu MC, Wu TS, Wu MT. A long-term risk-benefit analysis of low-dose aspirin in primary prevention. Eur J Clin Invest. 2016;46:130\u201340.","journal-title":"Eur J Clin Invest"},{"key":"474_CR3","first-page":"1","volume":"17","author":"P Sutcliffe","year":"2013","unstructured":"Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess. 2013;17:1\u2013253.","journal-title":"Health Technol Assess"},{"key":"474_CR4","doi-asserted-by":"crossref","first-page":"e81970","DOI":"10.1371\/journal.pone.0081970","volume":"8","author":"P Sutcliffe","year":"2013","unstructured":"Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Ngianga-Bakwin K, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One. 2013;8:e81970.","journal-title":"PLoS One"},{"key":"474_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-136-2-200201150-00016","volume":"136","author":"M Hayden","year":"2002","unstructured":"Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:161\u201372.","journal-title":"Ann Intern Med"},{"key":"474_CR6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tcm.2014.08.006","volume":"24","author":"CH Hennekens","year":"2014","unstructured":"Hennekens CH, Dalen JE. Aspirin in the primary prevention of cardiovascular disease: current knowledge and future research needs. Trends Cardiovasc Med. 2014;24:360\u20136.","journal-title":"Trends Cardiovasc Med"},{"key":"474_CR7","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849\u201360.","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"474_CR8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s10620-014-3415-9","volume":"60","author":"K Kawasaki","year":"2015","unstructured":"Kawasaki K, Kurahara K, Yanai S, Kochi S, Fuchigami T, Matsumoto T. Low-dose aspirin and non-steroidal anti-inflammatory drugs increase the risk of bleeding in patients with gastroduodenal ulcer. Dig Dis Sci. 2015;60:1010\u20135.","journal-title":"Dig Dis Sci"},{"key":"474_CR9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00535-011-0397-7","volume":"46","author":"K Sugano","year":"2011","unstructured":"Sugano K, Matsumoto Y, Itabashi T, Abe S, Sakaki N, Ashida K, et al. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial. J Gastroenterol. 2011;46:724\u201335.","journal-title":"J Gastroenterol"},{"key":"474_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/1756-0500-6-455","volume":"6","author":"N Kawamura","year":"2013","unstructured":"Kawamura N, Ito Y, Sasaki M, Iida A, Mizuno M, Ogasawara N, et al. Low-dose aspirin-associated upper gastric and duodenal ulcers in Japanese patients with no previous history of peptic ulcers. BMC Res Notes. 2013;6:455.","journal-title":"BMC Res Notes."},{"key":"474_CR11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(09)60938-7","volume":"374","author":"P Malfertheiner","year":"2009","unstructured":"Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009;374:1449\u201361.","journal-title":"Lancet"},{"key":"474_CR12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/apt.12907","volume":"40","author":"R Iwakiri","year":"2014","unstructured":"Iwakiri R, Higuchi K, Kato M, Fujishiro M, Kinoshita Y, Watanabe T, et al. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin. Aliment Pharmacol Ther. 2014;40:780\u201395.","journal-title":"Aliment Pharmacol Ther"},{"key":"474_CR13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00535-013-0839-5","volume":"49","author":"N Uemura","year":"2014","unstructured":"Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, et al. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol. 2014;49:814\u201324.","journal-title":"J Gastroenterol"},{"key":"474_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00228-006-0171-6","volume":"62","author":"C Sakamoto","year":"2006","unstructured":"Sakamoto C, Sugano K, Ota S, Takahashi S, Yoshida Y, Tsukui T, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol. 2006;62:765\u201372.","journal-title":"Eur J Clin Pharmacol"},{"key":"474_CR15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2036.2005.02476.x","volume":"21","author":"S Nakashima","year":"2005","unstructured":"Nakashima S, Arai S, Mizuno Y, Yoshino K, Ando S, Nakamura Y, et al. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2005;21:60\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"474_CR16","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3748\/wjg.v21.i17.5382","volume":"21","author":"C Mo","year":"2015","unstructured":"Mo C, Sun G, Lu ML, Zhang L, Wang YZ, Sun X, et al. Proton pump inhibitors in prevention of\u00a0low-dose\u00a0aspirin-associated upper gastrointestinal injuries. World J Gastroenterol. 2015;21:5382\u201392.","journal-title":"World J Gastroenterol"},{"key":"474_CR17","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.2174\/1381612821666150915105834","volume":"21","author":"K Sugano","year":"2015","unstructured":"Sugano K. Prevention of upper gastrointestinal ulcer and complications in\u00a0low-dose\u00a0aspirin\u00a0users. Curr Pharm Des. 2015;21:5082\u20138.","journal-title":"Curr Pharm Des"},{"key":"474_CR18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00535-015-1055-2","volume":"50","author":"N Nagata","year":"2015","unstructured":"Nagata N, Niikura R, Aoki T, Sakurai T, Moriyasu S, Shimbo T, et al. Effect of proton-pump inhibitors on the risk of lower gastrointestinal bleeding associated with NSAIDs,\u00a0aspirin, clopidogrel, and warfarin. J Gastroenterol. 2015;50:1079\u201386.","journal-title":"J Gastroenterol"},{"issue":"2\u20133","key":"474_CR19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000094098","volume":"73","author":"Y Mashita","year":"2006","unstructured":"Mashita Y, Taniguchi M, Yokota A, Tanaka A, Takeuchi K. Oral but not parenteral aspirin upregulates COX-2 expression in rat stomachs. a relationship between COX-2 expression and PG deficiency. Digestion. 2006;73(2\u20133):124\u201332.","journal-title":"Digestion."},{"issue":"Suppl 1","key":"474_CR20","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1007\/s10620-005-2802-7","volume":"50","author":"K Gudis","year":"2005","unstructured":"Gudis K, Sakamoto C. The role of cyclooxygenase in gastric mucosal protection. Dig Dis Sci. 2005;50(Suppl 1):S16\u201323.","journal-title":"Dig Dis Sci"},{"issue":"Suppl 3","key":"474_CR21","first-page":"67","volume":"57","author":"T Brzozowski","year":"2006","unstructured":"Brzozowski T, Konturek PC, Sliwowski Z, Kwiecie\u0144 S, Drozdowicz D, Pawlik M, et al. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. J Physiol Pharmacol. 2006;57(Suppl 3):67\u201379.","journal-title":"J Physiol Pharmacol"},{"key":"474_CR22","doi-asserted-by":"crossref","unstructured":"Iwamoto J, Saito Y, Honda A, Matsuzaki Y. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy. World J Gastroenterol.\u00a02013;19(11):1673\u201382.","DOI":"10.3748\/wjg.v19.i11.1673"},{"issue":"8","key":"474_CR23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1365-2036.2006.02856.x","volume":"23","author":"M Venerito","year":"2006","unstructured":"Venerito M, Treiber G, Wex T, Kuester D, Roessner A, Di Mario F, et al. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection. Aliment Pharmacol Ther. 2006;23(8):1225\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"474_CR24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/00365520801905296","volume":"43","author":"M Venerito","year":"2008","unstructured":"Venerito M, Treiber G, Wex T, Kuester D, Roessner A, M\u00f6nkem\u00fcller K, et al. Short-term\/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels. Scand J Gastroenterol. 2008;43(7):801\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"474_CR25","first-page":"249","volume":"16","author":"RQ Wang","year":"2002","unstructured":"Wang RQ, Xu SC. Changes of endogastric pH in 24\u00a0hours in patients with duodenal ulcer. Henan J Diagn Ther. 2002;16:249\u201350.","journal-title":"Henan J Diagn Ther."},{"issue":"6","key":"474_CR26","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.gie.2012.01.011","volume":"75","author":"DS Early","year":"2012","unstructured":"ASGE Standards of Practice Committee, Early DS, Ben-Menachem T, et al. Appropriate use of GI endoscopy. Gastrointest Endosc. 2012;75(6):1127\u201331.","journal-title":"Gastrointest Endosc"},{"key":"474_CR27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/138920021609151201113537","volume":"16","author":"T Nakanishi","year":"2015","unstructured":"Nakanishi T, Tamai I. Interaction of drug or food with drug transporters in intestine and liver. Curr Drug Metab. 2015;16:753\u201364.","journal-title":"Curr Drug Metab"},{"key":"474_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/bdd.1772","volume":"33","author":"CH Xu","year":"2012","unstructured":"Xu CH, Cheng G, Liu Y, Tian Y, Yan J, Zou MJ. Effect of the\u00a0timing\u00a0of\u00a0food\u00a0intake on the absorption and bioavailability of carbamazepine immediate-release tablets in beagle dogs. Biopharm Drug Dispos. 2012;33:30\u20138.","journal-title":"Biopharm Drug Dispos"},{"key":"474_CR29","first-page":"230","volume":"9","author":"XL Ying","year":"2010","unstructured":"Ying XL. Oral administration of enteric-coated tablets of aspirin are two days comparison gastric responses. Chin Med Mod Distance Educ China. 2010;9:230.","journal-title":"Chin Med Mod Distance Educ China."},{"key":"474_CR30","first-page":"457","volume":"8","author":"XF Lian","year":"2005","unstructured":"Lian XF, Xiang DC. Influence of administration time of enteric-coated tablets of aspirin on gastric adverse effects. Chin J Coal Ind Med. 2005;8:457\u20138.","journal-title":"Chin J Coal Ind Med."},{"key":"474_CR31","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","volume":"46","author":"AO Maree","year":"2005","unstructured":"Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, et al. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol. 2005;46:1258\u201363.","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-016-0474-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-016-0474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:07:58Z","timestamp":1498356478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-016-0474-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,26]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s40261-016-0474-z","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,26]]}}}